What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Internal medicine, Gastroenterology, Surgery, Helicobacter pylori and Inflammatory bowel disease are his primary areas of study.
His study in Ulcerative colitis, Clarithromycin, Adverse effect, Crohn's disease and Omeprazole is done as part of Internal medicine.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Odds ratio, Antibacterial agent, Disease and Meta-analysis.
His Surgery research includes themes of Clinical trial, Pharmacotherapy, Rifabutin and Levofloxacin.
His Helicobacter pylori research includes elements of Regimen, Antibiotics, MEDLINE and Proton-pump inhibitor.
The Inflammatory bowel disease study combines topics in areas such as Pregnancy, Anemia, Immunology, Azathioprine and Prospective cohort study.
His most cited work include:
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report (1623 citations)
- Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report (1149 citations)
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease : A Review (478 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Gastroenterology, Helicobacter pylori, Inflammatory bowel disease and Ulcerative colitis.
His research in Internal medicine focuses on subjects like Surgery, which are connected to Adverse effect.
He interconnects Prospective cohort study and Azathioprine in the investigation of issues within Gastroenterology.
His Helicobacter pylori research is multidisciplinary, incorporating perspectives in Regimen, Levofloxacin, Proton-pump inhibitor and Metronidazole.
His research in Inflammatory bowel disease intersects with topics in Tumor necrosis factor alpha and Immunology.
His study looks at the intersection of Ulcerative colitis and topics like Infliximab with Adalimumab.
He most often published in these fields:
- Internal medicine (65.31%)
- Gastroenterology (46.52%)
- Helicobacter pylori (25.75%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (65.31%)
- Inflammatory bowel disease (23.22%)
- Ulcerative colitis (17.43%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease.
When carried out as part of a general Internal medicine research project, his work on Helicobacter pylori, Adverse effect, Infliximab and Cohort is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
He combines subjects such as Regimen, Metronidazole and Levofloxacin with his study of Helicobacter pylori.
His research on Inflammatory bowel disease also deals with topics like
-
Immunology which intersects with area such as Intestinal mucosa,
-
Intensive care medicine and related MEDLINE,
-
Confidence interval that intertwine with fields like Odds ratio.
His Ulcerative colitis study integrates concerns from other disciplines, such as Colitis, Tofacitinib and Discontinuation.
His research on Gastroenterology also deals with topics like
-
Prospective cohort study that connect with fields like Interquartile range,
-
Retrospective cohort study which connect with Case-control study.
Between 2017 and 2021, his most popular works were:
- ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment (146 citations)
- Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study (77 citations)
- European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease. (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Javier P. Gisbert spends much of his time researching Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease.
His work in Adverse effect, Helicobacter pylori, Cohort, Cohort study and Meta-analysis are all subfields of Internal medicine research.
His Inflammatory bowel disease research incorporates themes from Retrospective cohort study, Immunology, Immune tolerance, Immune system and Hazard ratio.
His Ulcerative colitis research is multidisciplinary, incorporating elements of Discontinuation and Infliximab.
His work blends Gastroenterology and In patient studies together.
His work in Crohn's disease covers topics such as Confidence interval which are related to areas like Mixed anxiety-depressive disorder, Depression and Quality of life.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
